A Study of SKB264 (MK-2870; Sac-TMT) for the Treatment of Participants With Advanced or Metastatic Non-small Cell Lung Cancer (SKB264-II-04) (MK-2870-003)
Clinical trial NCT05816252 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05816252
- Sponsor
- Klus Pharma Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-19
- Primary completion
- 2026-06-30
- Enrollment
- 356
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.